Growth Hormone Secretagogues Explained — GHRP, GHRH & More

A comprehensive guide to peptides that stimulate natural growth hormone release — how they work, the major compounds compared, stacking strategies, dosing protocols, and what to expect.

Disclaimer: This content is for educational and informational purposes only and does not constitute medical advice. Growth hormone secretagogue peptides are research compounds not approved for human use. Always consult a qualified healthcare professional.

Growth hormone (GH) is one of the most important hormones for body composition, recovery, sleep quality, skin health, and overall vitality. Natural GH production peaks in adolescence and declines steadily — by age 40, most adults produce roughly half the GH they did at 20. Growth hormone secretagogues (GHS) offer a way to stimulate your body's own GH production without the risks, costs, and legal complications of exogenous HGH.

The GH secretagogue category includes several peptides with distinct pharmacological profiles — from the clean, selective stimulation of ipamorelin to the potent but side-effect-heavy punch of hexarelin. Understanding how these peptides work and differ is essential for designing an effective GH optimization protocol.

This guide covers the science, the compounds, the stacking strategies, and the practical details. For general peptide information, see our beginner's guide to peptides.

How Growth Hormone Secretagogues Work

Your body releases GH in pulses throughout the day, with the largest pulse occurring during deep sleep. Two hypothalamic hormones control this release: GHRH (growth hormone-releasing hormone) stimulates GH production, while somatostatin inhibits it. The interplay between these two creates the pulsatile pattern.

GH secretagogues work through two distinct receptor pathways:

GHRP Pathway (Ghrelin/GHS Receptor)

Growth hormone-releasing peptides (GHRPs) activate the ghrelin receptor (GHS-R1a) on pituitary somatotroph cells. This triggers an intracellular calcium signaling cascade that directly stimulates GH release. GHRPs also suppress somatostatin signaling, removing the “brake” on GH release. The result is a sharp GH pulse that peaks 15-30 minutes after injection. Peptides in this category: ipamorelin, GHRP-2, GHRP-6, hexarelin.

GHRH Pathway (GHRH Receptor)

GHRH analogues bind to the GHRH receptor on pituitary cells and amplify the magnitude of GH pulses. Rather than initiating a pulse (like GHRPs do), they increase the amplitude when a pulse is already occurring. This is why GHRH analogues alone produce modest GH elevation but dramatically amplify the effect when combined with a GHRP. Peptides in this category: CJC-1295 (no DAC), CJC-1295 (DAC), sermorelin, tesamorelin.

The Synergy of GHRP + GHRH

Combining a GHRP with a GHRH analogue produces synergistic GH release — typically 2-3x greater than either compound alone. The GHRP initiates a GH pulse and suppresses somatostatin, while the GHRH analogue amplifies the pulse amplitude. This is why the most common GH secretagogue protocol pairs ipamorelin (GHRP) with CJC-1295 no DAC (GHRH). See our ipamorelin/CJC-1295 vs tesamorelin comparison.

The Major GH Secretagogue Peptides Compared

GHRPs (Growth Hormone-Releasing Peptides)

  • Ipamorelin — the most selective GHRP. Stimulates GH with minimal cortisol, prolactin, or appetite effects. Dose-dependent and predictable. The go-to GHRP for most users. 200-300mcg SubQ, 1-3x daily. See ipamorelin vs GHRP-2 and ipamorelin vs GHRP-6.
  • GHRP-2 — stronger GH release than ipamorelin but also stimulates cortisol, prolactin, and appetite. Considered the most potent GHRP for raw GH output. 100-300mcg SubQ. See GHRP-2 vs GHRP-6.
  • GHRP-6 — similar potency to GHRP-2 but with significantly more appetite stimulation (powerful ghrelin-like hunger effect). Useful for individuals who need to increase caloric intake. 100-300mcg SubQ.
  • Hexarelin — the most potent GHRP for acute GH release. However, it causes significant cortisol and prolactin elevation and shows rapid desensitization with continuous use (effectiveness diminishes within 2-4 weeks). Best used in short cycles. See hexarelin vs ipamorelin.

GHRH Analogues

  • CJC-1295 (no DAC) / Mod GRF 1-29 — a modified GHRH analogue with a 30-minute half-life. Paired with ipamorelin for the synergistic GHRP+GHRH stack. 100mcg SubQ per injection, matched to GHRP timing. See CJC-1295 DAC vs no DAC.
  • CJC-1295 (DAC) — includes a Drug Affinity Complex that extends the half-life to 6-8 days. Creates a sustained elevation of baseline GH rather than pulsatile release. Dosed 1-2x per week at 1-2mg. Simpler protocol but does not preserve the natural pulsatile GH pattern.
  • Tesamorelin — the only FDA-approved GHRH analogue, specifically for HIV-associated lipodystrophy. Reduces visceral fat while preserving lean mass. Daily SubQ injection. More expensive due to pharmaceutical-grade production. See ipamorelin/CJC-1295 vs tesamorelin.

GH Secretagogue Stacking Protocols

The most effective GH secretagogue approach combines a GHRP with a GHRH analogue. Here are the most common evidence-informed protocols:

The Standard Stack: Ipamorelin + CJC-1295 (no DAC)

This is the most popular and well-tolerated GH secretagogue combination. Protocol: 200-300mcg ipamorelin + 100mcg CJC-1295 (no DAC), combined in the same syringe, injected SubQ 1-3 times daily. Optimal timing: upon waking (fasted) and before bed (2-3 hours post-dinner). Some users add a midday dose pre-workout. This protocol reliably elevates IGF-1 levels by 50-100% within 4-6 weeks.

The Simplified Stack: CJC-1295 (DAC) Only

For those who prefer fewer injections, CJC-1295 with DAC at 1-2mg once or twice weekly provides sustained GH elevation. The tradeoff is that it elevates baseline GH rather than amplifying natural pulses, which may provide fewer of the acute recovery and sleep benefits. This approach is simpler but generally considered less optimal than the pulsatile GHRP+GHRH combination.

Important Protocol Notes

  • Fasted administration is critical. Insulin blunts GH release. Wait 2+ hours after eating; wait 30 minutes after injection before eating.
  • Do not combine multiple GHRPs. Stacking ipamorelin + GHRP-2 + hexarelin does not multiply the effect — GHRPs compete for the same receptor. Use one GHRP at a time.
  • Cycling may be needed for hexarelin due to desensitization (2 weeks on, 2 weeks off). Ipamorelin and CJC-1295 do not show significant desensitization and can be used continuously.
  • Monitor IGF-1 levels via blood work after 4-6 weeks. Target a healthy elevation (150-300 ng/mL range for most adults) without excessive levels.

For broader stacking considerations beyond GH secretagogues, see our peptide stacking guide and Stack Builder tool.

Benefits & Applications of GH Secretagogues

Elevated growth hormone influences multiple systems throughout the body. The benefits of GH secretagogue therapy include:

  • Improved body composition — GH promotes fat oxidation (especially visceral fat) and supports lean mass maintenance. Not as dramatic as exogenous HGH but meaningful over months of use.
  • Enhanced recovery — faster recovery from exercise, injury, and surgery. GH plays a direct role in tissue repair and collagen synthesis. See our recovery peptides guide.
  • Better sleep quality — many users report deeper sleep, particularly with bedtime dosing. GH secretagogues amplify the natural nocturnal GH surge. See best peptides for sleep.
  • Skin, hair, and nail quality — GH stimulates collagen production, which improves skin elasticity and thickness over time. See peptides for skin and hair.
  • Joint health — GH-mediated collagen synthesis supports cartilage and connective tissue integrity. See best peptides for joints.
  • Anti-aging effects — age-related GH decline (somatopause) contributes to many aging-associated changes. Restoring more youthful GH levels may slow certain aging processes. See best peptides for anti-aging.

Benefits develop gradually over weeks to months. Improved sleep and recovery are typically noticed within 1-2 weeks. Body composition changes may take 8-12 weeks to become apparent. Skin and connective tissue improvements continue to develop over 3-6 months.

Key Takeaways

  • GH secretagogues stimulate natural GH production through the pituitary — they don't replace GH like exogenous HGH does.
  • The GHRP + GHRH combination is synergistic — pairing ipamorelin with CJC-1295 (no DAC) is the gold standard protocol.
  • Ipamorelin is the cleanest GHRP — minimal cortisol, prolactin, or appetite effects. Best for beginners and long-term use.
  • Fasted administration is non-negotiable — insulin blunts GH release. Time injections around meals carefully.
  • Benefits are gradual — expect sleep and recovery improvements in 1-2 weeks; body composition changes over 2-3 months.
  • Explore individual profiles in our peptide catalog, compare compounds with our comparison pages, or use the dosing calculator for concentration math.

Frequently Asked Questions

What is a growth hormone secretagogue?

A growth hormone secretagogue (GHS) is a compound that stimulates the pituitary gland to produce and release natural growth hormone. Unlike exogenous HGH (synthetic growth hormone), secretagogues work with your body's own GH production system. They come in two main categories: GHRH analogues (growth hormone-releasing hormone analogues like CJC-1295) that stimulate the GHRH receptor, and GHRPs (growth hormone-releasing peptides like ipamorelin and GHRP-2) that stimulate the ghrelin/GHS receptor. Combining both categories produces synergistic GH release.

What is the best growth hormone secretagogue for beginners?

Ipamorelin is widely considered the best GH secretagogue for beginners. It has the cleanest side effect profile of all GHRPs — it stimulates GH release with minimal impact on cortisol, prolactin, or appetite (unlike GHRP-2 and GHRP-6). It produces reliable, dose-dependent GH pulses. The standard beginner protocol is ipamorelin 200-300mcg subcutaneously, 1-2 times daily on an empty stomach. For enhanced results, it is commonly combined with CJC-1295 (no DAC) at 100mcg per injection.

How are GHRP and GHRH peptides different?

GHRP peptides (ipamorelin, GHRP-2, GHRP-6, hexarelin) stimulate the ghrelin/GHS receptor on the pituitary, triggering a GH pulse. GHRH peptides (CJC-1295, sermorelin, tesamorelin) stimulate the GHRH receptor, which amplifies the amplitude of GH pulses. Used alone, GHRPs produce moderate GH spikes. Used alone, GHRH analogues produce a mild increase. Combined, they produce synergistic GH release — the GHRH amplifies the pulse initiated by the GHRP, resulting in 2-3x more GH than either alone.

Do you need to take GH secretagogues on an empty stomach?

Yes. GH secretagogue peptides should be administered on an empty stomach — at least 2 hours after eating and at least 30 minutes before eating. This is because insulin and elevated blood glucose blunt the GH response. Even a small meal can reduce the GH pulse by 50% or more. The most popular timing is first thing in the morning (before breakfast) and/or before bed (at least 2-3 hours after dinner). Bedtime dosing aligns with the body's natural nocturnal GH surge.

What are the side effects of growth hormone secretagogues?

Common side effects vary by compound. Ipamorelin has the mildest profile — occasional water retention, mild headache, and slight tingling/numbness (from GH-mediated effects). GHRP-2 and GHRP-6 can increase appetite significantly (GHRP-6 is notorious for hunger spikes), raise cortisol, and elevate prolactin. Hexarelin is the most potent but causes the most cortisol and prolactin elevation and loses effectiveness with continuous use (desensitization). CJC-1295 with DAC can cause flushing and prolonged water retention due to its extended half-life.

Are growth hormone secretagogues the same as HGH?

No. Exogenous HGH (synthetic growth hormone) is a direct replacement — you inject GH itself, bypassing the pituitary entirely. GH secretagogues stimulate your own pituitary to produce more GH naturally. Key differences: secretagogues maintain the body's natural pulsatile GH release pattern (important for optimal effects), they carry lower risk of excessive GH/IGF-1 levels, they do not cause pituitary suppression, and they are not controlled substances (HGH is Schedule III in the US). However, secretagogues produce less total GH elevation than exogenous HGH.

Further Reading & Research

Explore independent research databases and regulatory resources.

Medical Disclaimer: This content is for informational and educational purposes only. It is not intended as medical advice. Growth hormone secretagogue peptides are research compounds. Always consult a qualified healthcare professional before using any peptide compound.

Advertisement
*not medical advice

Important Disclaimer

The content on this website is for informational and educational purposes only. It is not provided by licensed medical professionals and should not be interpreted as medical advice, diagnosis, or treatment recommendations. Before using any supplements, peptides, or related products, you are solely responsible for conducting your own research and consulting with a qualified healthcare provider. By continuing, you acknowledge and accept full responsibility for your decisions.